Suppr超能文献

糖尿病对丙型肝炎病毒感染患者预后的影响。

Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.

作者信息

Kita Yuki, Mizukoshi Eishiro, Takamura Toshinari, Sakurai Masaru, Takata Yoshiko, Arai Kuniaki, Yamashita Tatsuya, Nakamoto Yasunari, Kaneko Shuichi

机构信息

Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan.

出版信息

Metabolism. 2007 Dec;56(12):1682-8. doi: 10.1016/j.metabol.2007.07.011.

Abstract

Diabetes is a risk factor for the progression of liver fibrosis and development of hepatocellular carcinoma in chronic hepatitis C. However, the impact of diabetes on the long-term prognosis and the synergistic interactions of various host factors for diabetes to the progression of liver fibrosis are unknown. In the present study, we examined the host factors associated with the progression of hepatitis C in 68 patients with a posttransfusion hepatitis (PTH) and analyzed the relationships. Multivariate analysis showed that age of PTH, being male, and type 2 diabetes mellitus were risk factors for the progression of liver fibrosis. By the Kaplan-Meier method, the cirrhosis-free survival rates after the onset of PTH were significantly lower in the diabetic group than in the nondiabetic group (P < .01). Diabetes also had a great impact on the long-term prognosis of chronic hepatitis C by reducing the time from PTH to the occurrence of hepatocellular carcinoma (P < .01) and to liver-related death (P < .05). Coexistence of obesity (body mass index > or =25 kg/m(2)) or hypertriglyceridemia (> or =150 mg/dL) with diabetes had a synergistic effect on liver fibrosis progression in patients with chronic hepatitis C. Thus, the treatment of diabetes, obesity, and hypertriglyceridemia may hold the key to improving the prognosis of chronic hepatitis.

摘要

糖尿病是慢性丙型肝炎患者肝纤维化进展及肝细胞癌发生的危险因素。然而,糖尿病对长期预后的影响以及糖尿病与各种宿主因素在肝纤维化进展中的协同相互作用尚不清楚。在本研究中,我们调查了68例输血后肝炎(PTH)患者中与丙型肝炎进展相关的宿主因素,并分析了它们之间的关系。多因素分析显示,PTH发病年龄、男性以及2型糖尿病是肝纤维化进展的危险因素。采用Kaplan-Meier法分析,糖尿病组PTH发病后的无肝硬化生存率显著低于非糖尿病组(P <.01)。糖尿病还通过缩短从PTH发病到肝细胞癌发生的时间(P <.01)以及到肝脏相关死亡的时间(P <.05),对慢性丙型肝炎的长期预后产生重大影响。糖尿病合并肥胖(体重指数≥25 kg/m²)或高甘油三酯血症(≥150 mg/dL)对慢性丙型肝炎患者的肝纤维化进展具有协同作用。因此,治疗糖尿病、肥胖和高甘油三酯血症可能是改善慢性肝炎预后的关键。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验